The Efficacy and Safety of DLBS3233 in Adults With Prediabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT07937449
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT07937449
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Indonesia
- Registry status
- Completed
Technical summary
Registry record NCT07937449. Randomized; quadruple masking; primary purpose treatment. Start 2025-07-07 (actual); primary completion 2026-10-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy and Safety of DLBS3233 in Adults With Prediabetes
- Condition
- Prediabetes
- Intervention (Drug)
- DLBS3233
- Intervention (Drug)
- Metformin XR
- Lead sponsor
- Dexa Medica Group
- Collaborator
- PT Equilab International
Record details
- Record id
cardio:ct-nct07937449- Content hash
df26dfc6d26a1057bebeab4a20514452dfe2451a54d95669be7d801040674497